Predicting docetaxel benefit with a genomic classifier in #mHSPC. @ChrisSweens1 @SAiGENCI joins @TDorffOnc @cityofhope presenting a Decipher® genomic classifier analysis of the ENZAMET trial, applying the 22-gene assay to determine which patients with metastatic hormone-sensitive
